Related Experiment Video
Updated: Jul 13, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
High impact of depression in heart failure: early diagnosis and treatment options
Christine Norra1, Eric C Skobel, Marlies Arndt
1Department of Psychiatry and Psychotherapy, University Hospital, Aachen, Germany. norra@em.mpg.de
Insights
Depression is common in chronic heart failure (CHF) and worsens outcomes. Early diagnosis and integrated treatment of both conditions are crucial for better patient health and reduced healthcare costs.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Depressive syndromes frequently coexist with chronic heart failure (CHF), significantly increasing morbidity and mortality.
- This comorbidity negatively impacts daily functioning, hospitalization rates, and healthcare expenses.
- A low percentage of patients with comorbid CHF and depression receive adequate antidepressant treatment.
Purpose of the Study:
- To provide a comprehensive review of depression in CHF, including its prevalence, risk factors, and shared pathophysiology.
- To highlight the need for improved diagnosis and therapeutic strategies for depression in CHF patients.
- To examine the cardiac effects of various antidepressant therapies and offer treatment recommendations.
Main Methods:
- Literature review synthesizing current research on depression in chronic heart failure.
- Analysis of epidemiological data, etiological aspects, and pathophysiological links.
- Evaluation of pharmacological and non-pharmacological treatment options for depression in CHF.
Main Results:
- Depression in CHF is linked to poorer functional status (NYHA class) and increased hospitalizations.
- Shared psycho-organic factors may contribute to the bidirectional relationship between CHF and depression.
- Current treatment rates for depression in CHF patients remain insufficient.
Conclusions:
- Optimizing cardiological and psychiatric care is essential for managing depression in CHF.
- Early identification and treatment of depression can prevent adverse cardiac and neurological sequelae.
- Integrated therapeutic strategies, including psychopharmacological and non-pharmacological approaches, are recommended for better patient outcomes.
Abstract:
Depressive syndromes in chronic heart failure (CHF) are common and are associated with a poorer prognosis, particularly with increased morbidity and mortality. CHF as a severe physical disorder may increase the risk of developing depressive syndromes or vice-versa as an interaction of possible common psycho-organic etiological aspects. Depression in CHF is associated with impaired NYHA status and daily activities, resulting in enhanced hospitalisation rates and medical costs with a great impact on long-term health. Only a fraction of comorbid patients receives antidepressants. Therefore, identification of risk factors and prevention by optimizing cardiological and psychiatric therapeutic strategies appear essential for these patients. Early diagnosis and treatment of both CHF and depression may prevent further pathophysiological effects on the heart and brain. This review gives a comprehensive overview of the occurrence, risk factors and shared pathophysiology of depression in CHF, and focuses on improving insufficient diagnosis and therapy of depression. Special attention is given on the cardiac effects of psychopharmacological and alternate non-pharmacological antidepressant therapy in CHF. Recommendations are made for treating depression in CHF patients for a better prevention of this disabling physical and psychosocial condition.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure I: Introduction
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy V: Interprofessional Care